XTX Topco’s iTeos Therapeutics ITOS Stock Holding History

XTX Topco’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-34,777	Closed	-$347K	–	2896
2025 Q2	$347K	Buy	+34,777	New	+$280K	0.01%	1332
2025 Q1	–	Sell	-27,352	Closed	-$210K	–	2725
2024 Q4	$210K	Buy	27,352 +9,145	+50%	+$78.6K	0.02%	1517
2024 Q3	$186K	Buy	+18,207	New	+$278K	0.01%	1466

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

XTX Topco's ITOS Position: Q3 2025 in Review

XTX Topco sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 34,777 shares — an estimated $347K sold.

XTX Topco first reported a position in ITOS in Q3 2024 and held it in 3 quarters. The position peaked at $347K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

XTX Topco reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
XTX Topco sold 34,777 iTeos Therapeutics shares in Q3 2025, an estimated $347K.
XTX Topco first reported a position in iTeos Therapeutics in Q3 2024 and held it in 3 quarters.
XTX Topco's iTeos Therapeutics position peaked at $347K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.